Literature DB >> 8484624

Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation.

A M Schols1, P B Soeters, A M Dingemans, R Mostert, P J Frantzen, E F Wouters.   

Abstract

Prevalence and characteristics of nutritional depletion were established by body composition measurements in 255 COPD patients in stable clinical condition admitted to a pulmonary rehabilitation center. Depletion of body weight, fat-free mass (using bioelectrical resistance measurements), and muscle mass [from creatinine height index (CHI) and midarm muscle circumference] was most pronounced (40 to 50%) in patients suffering from chronic hypoxemia and in normoxemic patients with severe airflow obstruction (FEV1 < 35%) but also occurred in +/- 25% of patients with moderate airflow obstruction. Classification of the patients in four groups by body weight and fat-free mass revealed that depletion of fat-free mass may occur in normal-weight COPD patients (Group 3). These patients also exhibit a decreased CHI (61 +/- 21%, mean +/- SD) and suffer from physical impairment (12-min walking distance, WD, 532 +/- 152 m) to an even greater degree than underweight patients with relative preservation of fat-free mass (Group 2) (CHI = 73 +/- 16%; WD = 744 +/- 233 m). No systematic differences were established between the four groups in serum protein concentrations or medication use. We conclude that fat-free mass is a better indicator of body mass depletion than body weight. Classification of COPD patients by body weight and fat-free mass may have consequences for planning and interpretation of intervention strategies, particularly in Group 2 and 3 patients.

Entities:  

Mesh:

Year:  1993        PMID: 8484624     DOI: 10.1164/ajrccm/147.5.1151

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  101 in total

Review 1.  Enhancing physical performance in chronic obstructive pulmonary disease.

Authors:  M C Steiner; M D Morgan
Journal:  Thorax       Date:  2001-01       Impact factor: 9.139

Review 2.  The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies.

Authors:  Magali Poulain; Mariève Doucet; Geneviève C Major; Vicky Drapeau; Frédéric Sériès; Louis-Philippe Boulet; Angelo Tremblay; François Maltais
Journal:  CMAJ       Date:  2006-04-25       Impact factor: 8.262

Review 3.  [Comorbidities of COPD].

Authors:  H Watz; H Magnussen
Journal:  Internist (Berl)       Date:  2006-09       Impact factor: 0.743

4.  Sarcopaenia in chronic obstructive pulmonary disease.

Authors:  Michael C Steiner
Journal:  Thorax       Date:  2007-02       Impact factor: 9.139

5.  Abdominal obesity, sarcopenia, and osteoporosis are associated with frailty in men living with and without HIV.

Authors:  Kellie L Hawkins; Long Zhang; Derek K Ng; Keri N Althoff; Frank J Palella; Lawrence A Kingsley; Lisa P Jacobson; Joseph B Margolick; Jordan E Lake; Todd T Brown; Kristine M Erlandson
Journal:  AIDS       Date:  2018-06-19       Impact factor: 4.177

6.  Weight gain after lung reduction surgery is related to improved lung function and ventilatory efficiency.

Authors:  Victor Kim; Dana M Kretschman; Alice L Sternberg; Malcolm M DeCamp; Gerard J Criner
Journal:  Am J Respir Crit Care Med       Date:  2012-08-09       Impact factor: 21.405

7.  Fat-free mass depletion in patients with COPD in Brazil: development of a new cutoff point and its relation with mortality and extrapulmonary manifestations.

Authors:  A Travassos; A Rodrigues; K C Furlanetto; L Donária; G W Bisca; A G Nellessen; F Pitta; N A Hernandes
Journal:  Eur J Clin Nutr       Date:  2017-07-19       Impact factor: 4.016

8.  Quality of dietary intake in relation to body composition in patients with chronic obstructive pulmonary disease eligible for pulmonary rehabilitation.

Authors:  C van de Bool; C Mattijssen-Verdonschot; P P M J van Melick; M A Spruit; F M E Franssen; E F M Wouters; A M W J Schols; E P A Rutten
Journal:  Eur J Clin Nutr       Date:  2013-12-11       Impact factor: 4.016

9.  Altered tissue distribution in adults with cystic fibrosis.

Authors:  C E Bolton; A A Ionescu; W D Evans; R J Pettit; D J Shale
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

Review 10.  Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges.

Authors:  Vanessa M McDonald; Isabel Higgins; Peter G Gibson
Journal:  Drugs Aging       Date:  2013-01       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.